Design Therapeutics, Inc. (DSGN) vs Olema Pharmaceuticals, Inc. (OLMA)

Design Therapeutics, Inc. and Olema Pharmaceuticals, Inc. are both Biotechnology companies. Design Therapeutics, Inc. and Olema Pharmaceuticals, Inc. are of similar size ($809.3M and $791.0M). Across the 9 metrics below, Design Therapeutics, Inc. leads on 7 and Olema Pharmaceuticals, Inc. on 2.

Valuation

Metric DSGN OLMA Biotechnology median
P/E n/m n/m 7.88
P/S 3,363.10 n/m 11.47
P/B 3.77 2.12 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2,445.42 n/m 10.73
Earnings yield (9.70%) (24.23%) (28.84%)
Free cash flow yield (7.27%) (18.05%) (23.03%)

Profitability

Metric DSGN OLMA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (34.13%) (52.74%) (57.72%)
Return on assets (32.33%) (47.10%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DSGN OLMA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (38.64%) 15.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DSGN OLMA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 18.86 8.86 4.73
Net debt to EBITDA 2.68 2.82 0.96

Dividend

Metric DSGN OLMA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DSGN OLMA Biotechnology median
Market cap 809.26m 790.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack